HAINAN SHUANGCHENG PHARMACEUTICALS CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.02 CNY | +3.08% |
|
+2.87% | -33.16% |
| Mar. 18 | Hainan Shuangcheng Pharma's Unit Gets Green Light to Market Pregabalin Capsules | MT |
| Mar. 15 | Shuangcheng Pharmaceutical Gets Nod to Market Anticoagulant in Saudi Arabia | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Hainan Shuangcheng Pharmaceuticals Co., Ltd. is a China-based company principally engaged in the production, sale, research and development of chemically synthesized peptide drugs. The Company's main products include Jitai (thymalfasin for injection), for the treatment of various types of liver diseases, cancers, geriatric deseases and infectious diseases; thymopentin for infection; somatostatin, for the treatment of severe acute esophageal variceal bleeding and severe acute stomach or for the adjuvant therapy of duodenal ulcer bleeding and diabetic ketoacidosis, as well as other drugs. The Company distributes its products in domestic market and to overseas markets.
Sector
Pharmaceuticals
Calendar
2024-04-29
- Q1 2024 Earnings Release
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -33.16% | 289M | |
| +20.44% | 21.89B | |
| +14.04% | 14.45B | |
| +13.18% | 13.63B | |
| +37.83% | 11.49B | |
| -8.59% | 6.85B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +6.35% | 5.06B | |
| -5.36% | 4.66B |
- Stock Market
- Equities
- 002693 Stock
- News Hainan Shuangcheng Pharmaceuticals Co., Ltd.
- Hainan Shuangcheng Subsidiary Agrees to Paclitaxel Production
